Salmeterolo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Salmeterolo" in Italian language version.

refsWebsite

Global rank Italian rank

9nih.gov

4^th place

9^th place

2oadoi.org

799^th place

22^nd place

2doi.org

2^nd place

7^th place

2archive.org

6^th place

8^th place

1fda.gov

447^th place

644^th place

archive.org

PR. Butchers, CJ. Vardey; M. Johnson, Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung., in Br J Pharmacol, vol. 104, n. 3, Nov 1991, pp. 672-6, PMID 1724629.
M. Johnson, PR. Butchers; RA. Coleman; AT. Nials; P. Strong; MJ. Sumner; CJ. Vardey; CJ. Whelan, The pharmacology of salmeterol., in Life Sci, vol. 52, n. 26, 1993, pp. 2131-43, PMID 8099695.

doi.org

dx.doi.org

CJ. Cates, R. Jaeschke; S. Schmidt; M. Ferrer, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events., in Cochrane Database Syst Rev, vol. 3, Mar 2013, pp. CD006922, DOI:10.1002/14651858.CD006922.pub3, PMID 23543548.
R. Kempsford, A. Allen; J. Bal; D. Rubin; L. Tombs, The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects., in Br J Clin Pharmacol, vol. 75, n. 6, Giu 2013, pp. 1478-87, DOI:10.1111/bcp.12019, PMID 23116485.

fda.gov

Advair Diskus, Advair HFA, Brovana, Foradil, Perforomist, Serevent Diskus, and Symbicort Information (Long Acting Beta Agonists), su fda.gov, Food and Drug Administration, 18 novembre 2005. URL consultato il 9 agosto 2013.

nih.gov

ncbi.nlm.nih.gov

SR. Salpeter, NS. Buckley; TM. Ormiston; EE. Salpeter, Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths., in Ann Intern Med, vol. 144, n. 12, Giu 2006, pp. 904-12, PMID 16754916.
CJ. Cates, R. Jaeschke; S. Schmidt; M. Ferrer, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events., in Cochrane Database Syst Rev, vol. 3, Mar 2013, pp. CD006922, DOI:10.1002/14651858.CD006922.pub3, PMID 23543548.
PR. Butchers, CJ. Vardey; M. Johnson, Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung., in Br J Pharmacol, vol. 104, n. 3, Nov 1991, pp. 672-6, PMID 1724629.
M. Johnson, PR. Butchers; RA. Coleman; AT. Nials; P. Strong; MJ. Sumner; CJ. Vardey; CJ. Whelan, The pharmacology of salmeterol., in Life Sci, vol. 52, n. 26, 1993, pp. 2131-43, PMID 8099695.
A. Buchwald, G. Hochhaus, Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy., in Int J Clin Pharmacol Ther, vol. 36, n. 12, Dic 1998, pp. 652-60, PMID 9877002.
GR. Manchee, PJ. Eddershaw; LE. Ranshaw; D. Herriott; GR. Park; MK. Bayliss; MH. Tarbit, The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A., in Drug Metab Dispos, vol. 24, n. 5, Mag 1996, pp. 555-9, PMID 8723736.
R. Kempsford, A. Allen; J. Bal; D. Rubin; L. Tombs, The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects., in Br J Clin Pharmacol, vol. 75, n. 6, Giu 2013, pp. 1478-87, DOI:10.1111/bcp.12019, PMID 23116485.
A. López-Guillen, L. Marquès; MT. López-Llorente; E. Pastor; A. Figueras, Salmeterol-induced vertigo., in Eur Respir J, vol. 7, n. 11, Nov 1994, pp. 2089-90, PMID 7875287.
JR. Wilkinson, JA. Roberts; P. Bradding; ST. Holgate; PH. Howarth, Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler., in BMJ, vol. 305, n. 6859, Ott 1992, pp. 931-2, PMID 1360855.

oadoi.org

CJ. Cates, R. Jaeschke; S. Schmidt; M. Ferrer, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events., in Cochrane Database Syst Rev, vol. 3, Mar 2013, pp. CD006922, DOI:10.1002/14651858.CD006922.pub3, PMID 23543548.
R. Kempsford, A. Allen; J. Bal; D. Rubin; L. Tombs, The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects., in Br J Clin Pharmacol, vol. 75, n. 6, Giu 2013, pp. 1478-87, DOI:10.1111/bcp.12019, PMID 23116485.